Investor

Joyance Partners Announces SH², a New Fund Focused on Companies That Help People Live Longer and Better

Joyance Partners, investor in femtech companies like Attn: Grace, Rosy, Expectful, She’s Well, Unbound, and AOA Dx, has announced a new early-stage fund to invest in science centered companies that help people live longer, better, or both. The new fund’s investments will focus on 4 key outcomes, across 4 primary fields, driven by 4 science and technology vectors. “This layered structure allows…

Swiftarc Launches a New Fund Aimed at Women-Led Startups Building the Future of Beauty and Wellness

Swiftarc Ventues has announces a new §10M fund to invest in female-founded beauty and wellness companies. Swiftarc was founded by Sid Jawahar in 2019; this is the VCs fourth fund. In a recent interview with Techcrunch he explains: “The beauty industry in stuck in time where 75% to 80% of sales are still made from wholesale. E-commerce and digitally native brands are…

Early Stage Women’s Health VC Avestria Ventures Closes Fund I

Avestria Ventures invests in life science companies that have products or services which address unmet needs, improve healthcare quality and/or access, maintain or lower costs, and induce clinical or behavioral change. The company has now announced the closing of its new fund Avestria Ventures Fund I. Founded by veteran life science industry executives Linda Greub and Corinne Nevinny, Avestria invests in early-stage…

Supermoon Capital Launches a New $36M Fund Focused on Sleep

Supermoon Capital, formerly known as SleepScore Ventures, has announced the launch of its first $36M venture fund. Goal is to invest in early-stage startups across all geographies working on science-backed innovations aimed to improve sleep. With the world’s first fund investing in sleep, Supermoon Capital aims to address the rapidly emerging category of the “Night Market”, the firm’s name for the budding $488B…

Why Former 500 Startups Partner Paul Singh Is Bullish about Women’s Health and Looking to Build the “P&G of the 21st Century”

“Femtech funding lags behind the hype,” said Reenita Das of Frost & Sullivan, the firm whose infamous femtech market report helped put the women’s health innovation space on the map back in 2018 in a recent article. And we don’t disagree. Yes, femtech funding indeed lags behind, but the good news is that the times they are changing. Just last week, we…

The Overlooked Investment Opportunity: Menstrual Health

A Guest Post by The Case for Her in Celebration of Menstrual Hygiene Day. The Case for Her is a philanthropic investment portfolio focusing on the key women’s health areas of menstruation and sexual health and pleasure. We’re not your typical Femtech investors. We use investing as a tool in our philanthropy and to accomplish our goal of driving more funding into…

VIMPROs: Why Heal Capital Is Building a Community of Vertically Integrated Micro-Providers in Europe and Beyond

The consumerization of healthcare is well on the way as the recent rise in popularity of digital health has more and more patients looking for more convenience and an overall better care experience when accessing healthcare services. European VC Heal Capital has built a thesis based on this trend and backs mission-driven, category-defining healthtech companies. At the core of Heal Capital’s thesis…

CVS Health Launches a $100M Venture Fund

Earlier today CVS Health announced the launch of CVS Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler. “Consumers deserve a better health experience, one that puts them at the center of cutting-edge, digitally enabled solutions,” said Karen S. Lynch, President and CEO, CVS…